Characterizing the secretome of EGFR mutant lung adenocarcinoma

Characterizing the secretome of EGFR mutant lung adenocarcinoma

BackgroundLung cancer is the leading cause of cancer related death worldwide, mainly due to the late stage of disease at the time of diagnosis. Non-invasive biomarkers are needed to supplement existing screening methods to enable earlier detection and increased patient survival. This is critical to...

Full description

Bibliographic Details
Main Authors: Jennifer K. Luu, Fraser D. Johnson, Jana Jajarmi, Tianna Sihota, Rocky Shi, Daniel Lu, Dylan Farnsworth, Sandra E. Spencer, Gian Luca Negri, Gregg B. Morin, William W. Lockwood
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-01-01
Series:Frontiers in Oncology
Subjects:
lung cancer
EGFR
secretome
transformation
early detection
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1286821/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1286821/full

Similar Items